Thia Medica As

Evolva Sa

Karsten Kristiansen

Rolf Kristian Berge

Jean-Philippe Meyer

Alexandra c/o Evolva Sa Santana Sorensen

The present invention relates to fatty acid analogues of the general formula (I): R-[x-CH]&#x2014;COORwherein Ris; a C&#x2013;Calkene with one or more double bonds and/or with one or more triple bonds, and/or a C&#x2013;Calkyne, and/or a C&#x2013;Calkyl, or a C&#x2013;Calkyl substituted in one or several positions with one or more compounds selected from the group comprising fluoride, chloride, hydroxy, C&#x2013;Calkoxy, C&#x2013;Calkylthio, C&#x2013;Cacyloxy or C&#x2013;Calkyl, and wherein R2 represents hydrogen or C&#x2013;Calkyl, and wherein n is an integer from 1 to 12, and wherein i is an odd number and indicates the position relative to COOR, and wherein Xindependent of each other are selected from the group comprising O, S, SO, SO, Se and CH, and with the proviso that at least one of the Xis not CH, and with the proviso that if R1 is an alkyne or alkene, then the carbon-carbon triple bond or double bond is positioned between the (&#x3c9;-1) carbon and the (&#x3c9;-2) carbon, or between the (&#x3c9;-2) carbon and the (&#x3c9;-3) carbon, or between the (&#x3c9;-3) carbon and the (&#x3c9;-4) carbon, which can be used for the treatment and/or prevention of proliferative skin disorders. More specifically the invention relates to the inhibition of proliferation and/or differentiation of keratinocytes.

Growing community of inventors

Brody, Denmark

Karsten Kristiansen